1887
  1. Home
  2. Eurosurveillance
  3. Volume 31, Issue 28, 16/Jul/2026
  4. Article
Research Open Access
Like 0
Download

SDG 3: Antimicrobial resistance

Abstract

BACKGROUND

Hospital-onset bacteraemia and fungaemia (HOB) is a new target for automated surveillance of healthcare-associated infections.

AIM

We aimed to evaluate (i) whether data from a national laboratory-based antimicrobial resistance (AMR) surveillance system (ISIS-AR) are a suitable source for fully automated HOB surveillance and (ii) whether the derived HOB rates from automated surveillance are a useful measure for national surveillance.

METHODS

We applied an algorithm based on a consensus HOB definition to ISIS-AR data from 2018 to 2023. We performed: (i) technical evaluation of the data to determine their suitability for automated HOB surveillance, (ii) outcome validation of automatically identified HOB cases in four hospitals, and (iii) qualitative interviews with stakeholders on the anticipated value of HOB surveillance.

RESULTS

Most parameters required for HOB identification were present, except for hospital admission dates (≥ 80% available in only 14 hospitals). Outcome validation showed accurate identification of HOBs caused by pathogens (non-commensals), but identification of HOBs caused by common commensals varied between hospitals, reflecting laboratory policy differences. Interviewees emphasised that feedback from national HOB surveillance to hospitals can be valuable for monitoring local trends, as signal for in-depth investigations and benchmarking.

CONCLUSION

Dutch national automated HOB surveillance based on secondary use of national AMR surveillance data for pathogen-related HOBs is feasible, particularly if recording admission date is improved. Understanding local routine care and diagnostic practices is crucial for the interpretation of results. The main usefulness is expected at hospital level, while its value for national trend monitoring needs further study.

© Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2026.31.28.2500881
2026-07-16
2026-08-11
/content/10.2807/1560-7917.ES.2026.31.28.2500881
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/31/28/eurosurv-31-28-2.html?itemId=/content/10.2807/1560-7917.ES.2026.31.28.2500881&mimeType=html&fmt=ahah

References

  1. Storr J, Twyman A, Zingg W, Damani N, Kilpatrick C, Reilly J, et al. Core components for effective infection prevention and control programmes: new WHO evidence-based recommendations. Antimicrob Resist Infect Control. 2017;6(1):6.  https://doi.org/10.1186/s13756-016-0149-9  PMID: 28078082 
  2. van Mourik MSM, van Rooden SM, Abbas M, Aspevall O, Astagneau P, Bonten MJM, et al. PRAISE: providing a roadmap for automated infection surveillance in Europe. Clin Microbiol Infect. 2021;27(Suppl 1):S3-19.  https://doi.org/10.1016/j.cmi.2021.02.028  PMID: 34217466 
  3. Russo PL, Shaban RZ, Macbeth D, Carter A, Mitchell BG. Impact of electronic healthcare-associated infection surveillance software on infection prevention resources: a systematic review of the literature. J Hosp Infect. 2018;99(1):1-7.  https://doi.org/10.1016/j.jhin.2017.09.002  PMID: 28893614 
  4. van Mourik MS, Troelstra A, van Solinge WW, Moons KG, Bonten MJ. Automated surveillance for healthcare-associated infections: opportunities for improvement. Clin Infect Dis. 2013;57(1):85-93.  https://doi.org/10.1093/cid/cit185  PMID: 23532476 
  5. Verberk JDM, Aghdassi SJS, Abbas M, Nauclér P, Gubbels S, Maldonado N, et al. Automated surveillance systems for healthcare-associated infections: results from a European survey and experiences from real-life utilization. J Hosp Infect. 2022;122:35-43.  https://doi.org/10.1016/j.jhin.2021.12.021  PMID: 35031393 
  6. Sips ME, Bonten MJM, van Mourik MSM. Automated surveillance of healthcare-associated infections: state of the art. Curr Opin Infect Dis. 2017;30(4):425-31.  https://doi.org/10.1097/QCO.0000000000000376  PMID: 28505027 
  7. Dantes RB, Abbo LM, Anderson D, Hall L, Han JH, Harris AD, et al. Hospital epidemiologists’ and infection preventionists’ opinions regarding hospital-onset bacteremia and fungemia as a potential healthcare-associated infection metric. Infect Control Hosp Epidemiol. 2019;40(5):536-40.  https://doi.org/10.1017/ice.2019.40  PMID: 30932802 
  8. Dantes RB, Rock C, Milstone AM, Jacob JT, Chernetsky-Tejedor S, Harris AD, et al. Preventability of hospital onset bacteremia and fungemia: A pilot study of a potential healthcare-associated infection outcome measure. Infect Control Hosp Epidemiol. 2019;40(3):358-61.  https://doi.org/10.1017/ice.2018.339  PMID: 30773166 
  9. Rock C, Thom KA, Harris AD, Li S, Morgan D, Milstone AM, et al. A Multicenter Longitudinal Study of Hospital-Onset Bacteremia: Time for a New Quality Outcome Measure? Infect Control Hosp Epidemiol. 2016;37(2):143-8.  https://doi.org/10.1017/ice.2015.261  PMID: 26493213 
  10. Schrank GM, Sick-Samuels A, Bleasdale SC, Jacob JT, Dantes R, Gokhale RH, et al. Development and evaluation of a structured guide to assess the preventability of hospital-onset bacteremia and fungemia. Infect Control Hosp Epidemiol. 2022;43(10):1326-32.  https://doi.org/10.1017/ice.2021.528  PMID: 35086601 
  11. Yu KC, Ye G, Edwards JR, Gupta V, Benin AL, Ai C, et al. Hospital-onset bacteremia and fungemia: An evaluation of predictors and feasibility of benchmarking comparing two risk-adjusted models among 267 hospitals. Infect Control Hosp Epidemiol. 2022;43(10):1317-25.  https://doi.org/10.1017/ice.2022.211  PMID: 36082774 
  12. Aghdassi SJ, van der Werff SD, Catho G, Brekelmans M, Peña Diaz LA, Buetti N, et al. Hospital-onset bacteraemia and fungaemia as a novel automated surveillance indicator: results from four European university hospitals, 2018 to 2022. Euro Surveill. 2025;30(24):2400613.  https://doi.org/10.2807/1560-7917.ES.2025.30.24.2400613  PMID: 40539312 
  13. Altorf-van der Kuil W, Schoffelen AF, de Greeff SC, Thijsen SF, Alblas HJ, Notermans DW, et al. National laboratory-based surveillance system for antimicrobial resistance: a successful tool to support the control of antimicrobial resistance in the Netherlands. Euro Surveill. 2017;22(46):17-00062.  https://doi.org/10.2807/1560-7917.ES.2017.22.46.17-00062  PMID: 29162208 
  14. Centers for Disease Control and Prevention (CDC). Publication of Updated Guidelines for Evaluating Public Health Surveillance Systems. JAMA. 2001;286(12):1446.  https://doi.org/10.1001/jama.286.12.1446-JWR0926-2-1 
  15. Centers for Disease Control and Prevention (CDC). Master organism commensals list. Atlanta: CDC; 2024. Available from: www.cdc.gov/nhsn/xls/master-organism-com-commensals-lists.xlsx
  16. SNOMED International. SNOMED CT. London: SNOMED International. [Accessed: 16 Jun 2025]. Available from: https://snomed.org
  17. Regenstrief Institute. LOINC. Indianapolis: Regenstrief Institute. [Accessed: 16 Jun 2025]. Available from: https://loinc.org
  18. Brekelmans MACM, Vlek ALM, van Dijk Y, Smilde AE, Weersink AJL, Wunderink HF, et al. Automated surveillance of hospital-onset bacteremia and fungemia: feasibility and epidemiological results from a Dutch multicenter study. Infect Control Hosp Epidemiol. 2025;46(5):472-80.  https://doi.org/10.1017/ice.2025.29  PMID: 40007429 
  19. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77-101.  https://doi.org/10.1191/1478088706qp063oa 
  20. Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349-57.  https://doi.org/10.1093/intqhc/mzm042  PMID: 17872937 
  21. Prochaska EC, Xiao S, Colantuoni E, Clark RH, Johnson J, Mukhopadhyay S, et al. Hospital-Onset Bacteremia Among Neonatal Intensive Care Unit Patients. JAMA Pediatr. 2024;178(8):792-9.  https://doi.org/10.1001/jamapediatrics.2024.1840  PMID: 38913368 
  22. Gandra S, Singh SK, Chakravarthy M, Moni M, Dhekane P, Mohamed Z, et al. Epidemiology and preventability of hospital-onset bacteremia and fungemia in 2 hospitals in India. Infect Control Hosp Epidemiol. 2024;45(2):157-66.  https://doi.org/10.1017/ice.2023.170  PMID: 37593953 
  23. Prochaska EC, Xiao S, Colantuoni E, Elhaissouni N, Clark RH, Johnson J, et al. Hospital-onset bacteremia in the neonatal intensive care unit: strategies for risk adjustment. Infect Control Hosp Epidemiol. 2025;46(4):370-6.  https://doi.org/10.1017/ice.2024.238  PMID: 39957280 
  24. Haustein T, Gastmeier P, Holmes A, Lucet J-C, Shannon RP, Pittet D, et al. Use of benchmarking and public reporting for infection control in four high-income countries. Lancet Infect Dis. 2011;11(6):471-81.  https://doi.org/10.1016/S1473-3099(10)70315-7  PMID: 21616457 
  25. El-Saed A, Balkhy HH, Weber DJ. Benchmarking local healthcare-associated infections: available benchmarks and interpretation challenges. J Infect Public Health. 2013;6(5):323-30.  https://doi.org/10.1016/j.jiph.2013.05.001  PMID: 23999329 
  26. Harris AD, McGregor JC. The importance of case-mix adjustment for infection rates and the need for more research. Infect Control Hosp Epidemiol. 2008;29(8):693-4.  https://doi.org/10.1086/590471  PMID: 18643745 
  27. Søgaard M, Lyytikäinen O, Laupland KB, Schønheyder HC. Monitoring the epidemiology of bloodstream infections: aims, methods and importance. Expert Rev Anti Infect Ther. 2013;11(12):1281-90.  https://doi.org/10.1586/14787210.2013.856262  PMID: 24188131 
  28. Mølbak K, Andersen CØ, Dessau RB, Ellermann-Eriksen S, Gubbels S, Jensen TG, et al. Mandatory surveillance of bacteremia conducted by automated monitoring. Front Public Health. 2024;12:1502739.  https://doi.org/10.3389/fpubh.2024.1502739  PMID: 39737463 
  29. European Centre for Disease Prevention and Control (ECDC). High-level antimicrobial resistance meeting in Brussels. Stockholm: ECDC; 2024. Available from: https://www.ecdc.europa.eu/en/news-events/high-level-antimicrobial-resistance-meeting-brussels
  30. European Commission. European Health Data Space Regulation (EHDS). Brussels: European Commission. [Accessed: 11 Feb 2026]. Available from: https://health.ec.europa.eu/ehealth-digital-health-and-care/european-health-data-space-regulation-ehds_en
  31. van Rooden SM, van der Werff SD, van Mourik MSM, Lomholt F, Møller KL, Valk S, et al. Federated systems for automated infection surveillance: a perspective. Antimicrob Resist Infect Control. 2024;13(1):113.  https://doi.org/10.1186/s13756-024-01464-8  PMID: 39334278 
National automated surveillance of hospital onset bacteraemia and fungaemia using data from the national antimicrobial resistance surveillance system: a retrospective exploratory evaluation, the Netherlands, 2018 to 2023
<p class="citation"> <span>Citation style for this article:</span> <span class="meta-value authors"> <a href="/search?value1=Manon+Brekelmans&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Brekelmans Manon</a>, <a href="/search?value1=Tjallie+van+der+Kooi&option1=author&noRedirect=true" class="nonDisambigAuthorLink">van der Kooi Tjallie</a>, <a href="/search?value1=Annelot+F+Schoffelen&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Schoffelen Annelot F</a>, <a href="/search?value1=Rony+E+Zoetigheid&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Zoetigheid Rony E</a>, <a href="/search?value1=Maaike+SM+van+Mourik&option1=author&noRedirect=true" class="nonDisambigAuthorLink">van Mourik Maaike SM</a>, <a href="/search?value1=Sabine+de+Greeff&option1=author&noRedirect=true" class="nonDisambigAuthorLink">de Greeff Sabine</a>, <a href="/search?value1=Stephanie+van+Rooden&option1=author&noRedirect=true" class="nonDisambigAuthorLink">van Rooden Stephanie</a>, <a href="/search?value1=on+behalf+of+the+ISIS-AR+study+group&option1=author&noRedirect=true" class="nonDisambigAuthorLink">on behalf of the ISIS-AR study group</a></span>. National automated surveillance of hospital onset bacteraemia and fungaemia using data from the national antimicrobial resistance surveillance system: a retrospective exploratory evaluation, the Netherlands, 2018 to 2023. <a href="/content/ecdc">Euro Surveill.</a> 2026;31(28):pii=2500881. <a href="https://doi.org/10.2807/1560-7917.ES.2026.31.28.2500881" title="doi link" target="_blank">https://doi.org/10.2807/1560-7917.ES.2026.31.28.2500881</a> <span class="ES_Article_citation"> <span class="generated">Received</span>: 17 Nov 2025;&nbsp;&nbsp; <span class="generated">Accepted</span>: 05 Mar 2026 </span> </p>
/content/10.2807/1560-7917.ES.2026.31.28.2500881
/content/10.2807/1560-7917.ES.2026.31.28.2500881
Loading

Data & Media loading...

Supplementary data

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error